acetyl-l-carnitine hepatic encephalopathy trial 500 mg acetyl-l-carnitine hepatic encephalopathy randomized trial

those with permanent malabsorption may receive boosters every three to six months, guided by periodic laboratory assessment and clinical response

doi:10.1096/fasebj.10.4.8647346

Consult a licensed healthcare provider before making any health-related decisions

:

This research was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), grant number KL2900/3-1 (to KK) and by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), grant numbers TR156/C05-246807620, SFB1009/B11-194468054, SFB1066/B06-213555243, SFB1450/C06-431460824 (to KS) and by NIH grants 1R01AR073004 and R01AR071189, VA merit 1I01BX004293-01A1 and DOD grant W81XWH2210689 (to AS) and Rowe-Smith Foundation Grant (to RR)